Acadia Healthcare (NASDAQ:ACHC) Hits New 12-Month Low – Here’s Why

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) hit a new 52-week low on Tuesday . The company traded as low as $12.50 and last traded at $12.64, with a volume of 1387869 shares. The stock had previously closed at $13.23.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on ACHC shares. UBS Group dropped their target price on shares of Acadia Healthcare from $28.00 to $24.00 and set a “buy” rating on the stock in a research report on Wednesday, December 3rd. Guggenheim lowered their price objective on shares of Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating for the company in a research note on Monday, November 10th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating on the stock in a research note on Wednesday, December 3rd. Leerink Partnrs lowered shares of Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 3rd. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, October 8th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Acadia Healthcare presently has a consensus rating of “Hold” and an average price target of $18.82.

Acadia Healthcare Price Performance

The company has a 50-day moving average of $15.44 and a 200 day moving average of $20.23. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $1.16 billion, a PE ratio of 10.73, a PEG ratio of 3.55 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. Acadia Healthcare had a net margin of 3.29% and a return on equity of 7.66%. The business had revenue of $851.57 million during the quarter, compared to analyst estimates of $852.43 million. During the same quarter in the prior year, the firm earned $0.91 earnings per share. The company’s revenue for the quarter was up 4.4% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Allworth Financial LP boosted its holdings in Acadia Healthcare by 676.4% during the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after acquiring an additional 1,177 shares during the period. EverSource Wealth Advisors LLC lifted its position in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares in the last quarter. Hantz Financial Services Inc. boosted its stake in shares of Acadia Healthcare by 501.9% in the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock valued at $54,000 after purchasing an additional 1,822 shares during the period. CWM LLC grew its holdings in shares of Acadia Healthcare by 105.1% in the second quarter. CWM LLC now owns 2,633 shares of the company’s stock valued at $60,000 after purchasing an additional 1,349 shares in the last quarter. Finally, Quent Capital LLC purchased a new stake in Acadia Healthcare during the 3rd quarter worth approximately $71,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.